Ryuichi Harada1, Ai Yanai1,2, Ren Iwata3, Takeo Yoshikawa1, Yoichi Ishikawa3, Shozo Furumoto3, Kazuhiko Yanai1,3 (1.Department of Pharmacology, Tohoku University Graduate School of Medicine, 2.Department of Surgical Oncology, Tohoku University Gradate School of Medicine, 3.Cyclotron and Radioisotope Center (CYRIC), Tohoku University)
Session information
[JSMN]Radiopharmaceutical:Labeling・Synthesis
Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [JSMN]Digital Poster (Oral)
Radiopharmaceutical:Labeling・Synthesis
Thu. Nov 15, 2018 3:15 PM - 4:15 PM Digital Poster (Exhibition Hall 1F Booth1)
Chair:Shozo Furumoto (Cyclotoron and Radioisotope Center, Tohoku Univesity)
Masayuki Fujinaga1, Takayuki Ohkubo1,2, Katsushi Kumata1, Wakana Mori1, Ming-Rong Zhang1 (1.National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, Chiba, Japan, 2.SHI Accelerator Service Ltd, Tokyo, Japan)
Takayuki Ohkubo1,2, Masayuki Fujinaga2, Katsushi Kumata2, Nobuki Nengaki1,2, Ming-Rong Zhang2 (1.SHI Accelerator Service Co. Ltd. Tokyo, Japan, 2.Department of Radiopharmaceuticals Development National Institute of Radiological Sciences National Institutes for Quantum and Radiological Science and Technology Chiba, Japan)
Tomoyuki Ohya, Kotaro Nagatsu, Katsuyuki Minegishi, Masayuki Hanyu, Hisashi Suzuki, Masami Fukada, Ming-Rong Zhang (National Institutes for Quantum and Radiological Science and Technology (QST), National Institute of Radiological Sciences (NIRS), Chiba, Japan)
Hisashi Suzuki, Tomoyuki Ohya, Kotaro Nagatsu, Masami Fukada, Katsuyuki Minegishi, Ming-Rong Zhang (National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science Technology, Tiba, Japan)
Kazuki Aita1, Masahiro Sasaki1, Aya Mawatari2, Hisashi Doi2, Yasuyoshi Watanabe2, Michio Senda1 (1.Kobe City Medical Center General Hospital, Kobe, Japan, 2.RIKEN Center for Biosystems Dynamics Research, Kobe, Japan)
Yasukazu Kanai1,2,3, Youichiro Ohta4, Yoshihide Hattori4,6, Tomohiro Yoshikawa6, Sadahiro Naka7, Toshihiro Sakai5, Kouki Uehara6, Hiroshi Takenaka4,6, Eku Shimosegawa7, Mitsunori Kirihata4, Jun Hatazawa7 (1.Molecular Imaging in Medicine, Osaka Univesity Graduate School of Medicine, Osaka, Japan, 2.Department of Biofunctional Analysis, Osaka University of Pharmaceutical Science, Osaka, Japan, 3.Kansai BNCT Medical Center, Osaka Medical College, Osaka, Japan, 4.Research Center for BNCT, Osaka Prefucture University, Sakai, Japan, 5.Hanwa Intelligent Medical Center, Sakai, Japan, 6.Stella Pharma Corporation, Osaka, Japan, 7.Department of Nulclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan)